161 related articles for article (PubMed ID: 37259388)
1. Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells.
Gan Y; Li X; Han S; Zhou L; Li W
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259388
[TBL] [Abstract][Full Text] [Related]
2. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
[TBL] [Abstract][Full Text] [Related]
3. Survivin degradation by bergenin overcomes pemetrexed resistance.
Li X; Liang Q; Zhou L; Deng G; Xiao Y; Gan Y; Han S; Liao J; Wang R; Qing X; Li W
Cell Oncol (Dordr); 2023 Dec; 46(6):1837-1853. PubMed ID: 37542022
[TBL] [Abstract][Full Text] [Related]
4. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer.
Yu X; Gao F; Li W; Zhou L; Liu W; Li M
J Exp Clin Cancer Res; 2020 Apr; 39(1):62. PubMed ID: 32276600
[TBL] [Abstract][Full Text] [Related]
5. Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination.
Wang R; Li X; Wang J
J Cancer; 2024; 15(10):3173-3182. PubMed ID: 38706892
[TBL] [Abstract][Full Text] [Related]
6. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
[TBL] [Abstract][Full Text] [Related]
7. Trametinib potentiates TRAIL-induced apoptosis via FBW7-dependent Mcl-1 degradation in colorectal cancer cells.
Lin L; Ding D; Xiao X; Li B; Cao P; Li S
J Cell Mol Med; 2020 Jun; 24(12):6822-6832. PubMed ID: 32352219
[TBL] [Abstract][Full Text] [Related]
8. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
Tong J; Tan S; Zou F; Yu J; Zhang L
Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335
[TBL] [Abstract][Full Text] [Related]
9. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
[TBL] [Abstract][Full Text] [Related]
10.
Tong J; Tan S; Nikolovska-Coleska Z; Yu J; Zou F; Zhang L
Mol Cancer Ther; 2017 Sep; 16(9):1979-1988. PubMed ID: 28619760
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7.
Kim YJ; Kim Y; Kumar A; Kim CW; Toth Z; Cho NH; Lee HR
PLoS Pathog; 2021 Jan; 17(1):e1009179. PubMed ID: 33471866
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.
Kim MJ; Chen G; Sica GL; Deng X
Cancer Biol Ther; 2021 Jan; 22(1):55-65. PubMed ID: 33336620
[TBL] [Abstract][Full Text] [Related]
13. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.
Yu X; Zhou L; Liu W; Liu L; Gao F; Li W; Liu H
Cell Death Dis; 2022 Mar; 13(3):249. PubMed ID: 35301297
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of EGFR Signaling and Activation of Mitochondrial Apoptosis Contribute to Tanshinone IIA-Mediated Tumor Suppression in Non-Small Cell Lung Cancer Cells.
Gao F; Li M; Liu W; Li W
Onco Targets Ther; 2020; 13():2757-2769. PubMed ID: 32308411
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
[TBL] [Abstract][Full Text] [Related]
17. Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.
Schulze-Bergkamen H; Ehrenberg R; Hickmann L; Vick B; Urbanik T; Schimanski CC; Berger MR; Schad A; Weber A; Heeger S; Galle PR; Moehler M
World J Gastroenterol; 2008 Jun; 14(24):3829-40. PubMed ID: 18609706
[TBL] [Abstract][Full Text] [Related]
18. A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling.
Yu Z; Du J; Zhao Y; Gao Y; Li Y; Zhao K; Lu N
Cancer Lett; 2021 Feb; 498():31-41. PubMed ID: 33129955
[TBL] [Abstract][Full Text] [Related]
19. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
[TBL] [Abstract][Full Text] [Related]
20. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
